JACOBS LEVY EQUITY MANAGEMENT, INC
Position in EVH — Evolent Health, Inc.
CIK 884414
FLORHAM PARK, NJ
Position in EVH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,391,032
-$7,684,456 QoQ
Shares Held
610,102
-73.1% QoQ
Ownership
0.542%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
7 quarters on record
Voting authority
Sole 57.33008578893365.ToString("F0")%
Shared 0.ToString("F0")%
None 42.66991421106635.ToString("F0")%
Common Shares in EVH Over Time
Shares Held
Position Value (USD)
Position in Health Information Services
Healthcare · as of Mar 31, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $97,670,973 across 12 Health Information Services names. EVH ranks #8 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TXG |
10x Genomics, Inc.
|
2,283,424 | $48,477,091 | |
| 2 | OMCL |
Omnicell, Inc.
|
502,700 | $16,780,126 | |
| 3 | PHR |
Phreesia, Inc.
|
1,075,760 | $9,014,868 | |
| 4 | HSTM |
Healthstream Inc
|
288,179 | $5,968,187 | |
| 5 | OMDA |
Omada Health, Inc.
|
395,238 | $4,968,141 | |
| 6 | WEAV |
Weave Communications, Inc.
|
929,483 | $4,294,211 | |
| 7 | HNGE |
Hinge Health, Inc.
|
110,088 | $4,244,993 | |
| 8 | EVH |
Evolent Health, Inc.
This page
|
610,102 | $1,391,032 |
All Filings in EVH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,391,032 | 610,102 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,075,488 | 2,268,872 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,006,500 | 1,773,818 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $7,561,698 | 671,554 | Shares | Sole | 2025-08-14 | |
| 2022-12-31 | $738,784 | 26,310 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,208,388 | 228,455 | Shares | Sole | 2022-11-15 | |
| 2020-03-31 | $493,044 | 90,800 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||